SC 13G Filing

Company

Karyopharm Therapeutics Inc.

Filed

December 8, 2020

Accession Number

0000834237-20-010549

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →